TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/28/24 16:17 | 2/26/24 | QURE | Uniqure N.V. | Health | Drug | Pharmaceutical Preparations | Kapusta Matthew C | P7 | DO | CEO,MD | S | -177 | 6.35 | 0 | -28 | -6 | 441 | D | |||||||||||||||
3/9/23 16:58 | 3/7/23 | QURE | Uniqure N.V. | Health | Drug | Pharmaceutical Preparations | Kapusta Matthew C | DO | CEO,MD | S | -54 | 21.39 | 0 | -3 | -1 | 469 | D | ||||||||||||||||
3/1/23 16:13 | 2/27/23 | QURE | Uniqure N.V. | Health | Drug | Pharmaceutical Preparations | Kapusta Matthew C | P7 | DO | CEO,MD | S.m | -493 | 20.09 | 0 | -25 | -5 | 471 | D | |||||||||||||||
12/13/22 15:34 | 12/9/22 | QURE | Uniqure N.V. | Health | Drug | Pharmaceutical Preparations | Kapusta Matthew C | DO | CEO,MD | S | -149 | 22.44 | 0 | -7 | -2 | 368 | D | ||||||||||||||||
3/2/22 17:01 | 2/28/22 | QURE | Uniqure N.V. | Health | Drug | Pharmaceutical Preparations | Kapusta Matthew C | P7 | DO | CEO,MD | S | -170 | 16.70 | 0 | -10 | -3 | 361 | D | |||||||||||||||
1/28/22 16:56 | 1/26/22 | QURE | Uniqure N.V. | Health | Drug | Pharmaceutical Preparations | Kapusta Matthew C | P7 | O | CEO,CFO, | S | -197 | 18.10 | 0 | -11 | -4 | 246 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |